Mark Mikhael, nombrado farmacéutico del año por la Sociedad de Farmacéuticos de Sistemas de Salud de Florida.
The prestigious honor recognizes Mikhael’s exceptional leadership, commitment to advancing patient care, and significant contributions to the pharmaceutical industry across Florida
ORLANDO, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) — Recognized for his leadership in advancing compounding, championing patient access, and shaping the future of pharmacy, Mark Mikhael, PharmD, CEO of Olympia and Wesley Pharmaceuticals, has been named Pharmacist of the Year by the Florida Society of Health-System Pharmacists (FSHP). This honor recognizes exceptional vision, professional excellence, and a steadfast commitment to improving healthcare for communities across Florida and beyond.
Under Mikhael’s guidance, Olympia and Wesley Pharmaceuticals, two of the nation’s leading compound pharmacies, have expanded access to high-quality medications while driving industry-wide conversations about affordability and innovation in patient care. His advocacy extends beyond the boardroom, with a deep commitment to ensuring compounding remains a vital part of modern medicine.
“It is a tremendous honor to be recognized by FSHP with this award,” said Mikhael. “This achievement reflects the dedication of our entire team, whose passion for compounding and patient care inspires me daily. We remain committed to breaking down barriers so patients can access the medication they need, when they need it.”
Throughout his career, Mikhael has served as a bridge between policymakers, providers, and patients, helping to shape regulations that protect access to compounded medications while educating stakeholders about their critical role in healthcare. His leadership has helped safeguard options for patients with unique needs that mass-produced drugs cannot meet.
“Mark’s unwavering advocacy for compounding and his dedication to patient access exemplify the highest standards of our profession. His work has made a lasting difference for both pharmacists and the patients they serve,” said Stan Loomis, co-founder of Olympia and Wesley Pharmaceuticals.
Mikhael’s recognition by FSHP underscores a career defined by collaboration and forward-thinking solutions. Whether testifying on behalf of compounding legislation, building strategic partnerships, or mentoring the next generation of pharmacists, he continues to set a high standard for leadership within the industry.
“From the moment Mark joined our team, it was clear he shared our passion for innovation and patient care. His leadership has strengthened our mission, expanded our impact, and ensured we remain at the forefront of compounding pharmacy,” said Naomi Loomis, co-founder of Olympia and Wesley Pharmaceuticals.
The Pharmacist of the Year award is one of FSHP’s most significant honors, given annually to a member who demonstrates outstanding service, professional excellence, and a lasting impact on pharmacy practice.
Para obtener más información sobre Olympia Pharmaceuticals, visite olympiapharmacy.com, y para obtener más información sobre Wesley Pharmaceuticals, visite wesleypharmaceuticals.com.
Acerca de Olympia Pharmaceuticals
Olympia Pharmaceuticals una instalación farmacéutica de vanguardia, registrada por la FDA como 503B, dedicada a la subcontratación y como farmacia 503A, que atiende las necesidades específicas de los pacientes y de los consultorios en todo Estados Unidos. Fundada conjuntamente por Stan y Naomi Loomis, el equipo está formado por técnicos farmacéuticos, farmacéuticos, personal de calidad e ingenieros, lo que da lugar a una plantilla cualificada y con experiencia, conocedora de todas las facetas de la producción farmacéutica. Como centro de externalización registrado por la FDA, Olympia ofrece medicamentos compuestos a 48 estados, tanto para uso en consultorios como para recetas de pacientes. Olympia se especializa en pérdida de peso, dermatología, terapia nutricional intravenosa, disfunción eréctil y más.
Acerca de Wesley Pharmaceuticals
Wesley Pharmaceuticals, una marca hermana de Olympia Pharmaceuticals, fue fundada por Stan y Naomi Loomis en 2024 en honor a Wesley Loomis, su hijo y un querido miembro del equipo. Con sede en Orlando, Florida, la empresa tiene previsto suministrar medicamentos compuestos de alta calidad en diversas áreas terapéuticas, entre ellas el control del peso, la terapia de reemplazo hormonal y el bienestar. Basada en la compasión y la atención centrada en el paciente, Wesley se dedica a apoyar a las farmacias y los proveedores con soluciones innovadoras que mejoran la vida de las personas.
